BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1333665)

  • 1. Cross-reactivity of existing equine influenza vaccines with a new strain of equine influenza virus from China.
    Chambers TM
    Vet Rec; 1992 Oct; 131(17):388-91. PubMed ID: 1333665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)--a new equine influenza virus.
    Webster RG; Thomas TL
    Vaccine; 1993; 11(10):987-93. PubMed ID: 8212831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field observations on influenza vaccination among horses in Britain, 1971-1976.
    Powell DG; Burrows R; Spooner P; Mumford J; Thomson G
    Dev Biol Stand; 1977 Jun 1-3; 39():347-52. PubMed ID: 604119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses.
    Bogdan JR; Morley PS; Townsend HG; Haines DM
    Can J Vet Res; 1993 Apr; 57(2):126-30. PubMed ID: 8387870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
    Newton JR; Townsend HG; Wood JL; Sinclair R; Hannant D; Mumford JA
    Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against equine herpesvirus 1 and equine influenza infection.
    Witherspoon DM
    Vet Rec; 1984 Oct; 115(14):363. PubMed ID: 6093330
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
    Mumford J; Wood JM; Scott AM; Folkers C; Schild GC
    J Hyg (Lond); 1983 Jun; 90(3):385-95. PubMed ID: 6306098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
    Morley PS; Townsend HG; Bogdan JR; Haines DM
    J Am Vet Med Assoc; 1999 Jul; 215(1):61-6. PubMed ID: 10397067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological investigation of racehorse vaccination against equine influenza in Morocco.
    Dilai M; Piro M; Fougerolle S; El Harrak M; Mahir W; El Mourid R; Legrand L; Paillot R; Fassi Fihri O
    Vet Microbiol; 2018 Sep; 223():153-159. PubMed ID: 30173741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updating equine influenza strains in a combined equine influenza and herpesvirus vaccine.
    Cullinane AA
    Vet J; 2004 Mar; 167(2):118-20. PubMed ID: 14975382
    [No Abstract]   [Full Text] [Related]  

  • 13. Equine influenza vaccine efficacy: the significance of antigenic variation.
    Yates P; Mumford JA
    Vet Microbiol; 2000 May; 74(1-2):173-7. PubMed ID: 10799789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiological and molecular evidence for the presence of two H3N8 equine influenza viruses in China in 1993-94.
    Guo Y; Wang M; Zheng GS; Li WK; Kawaoka Y; Webster RG
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():2009-14. PubMed ID: 7636481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination.
    Breathnach CC; Rudersdorf R; Lunn DP
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):127-36. PubMed ID: 15010222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for immunity against equine influenza virus infections.
    Bürki F; Lamatsch O
    Comp Immunol Microbiol Infect Dis; 1981; 4(3-4):267-78. PubMed ID: 6174266
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus.
    Mumford JA; Wood JM; Folkers C; Schild GC
    Epidemiol Infect; 1988 Jun; 100(3):501-10. PubMed ID: 2837409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible basis of adverse reactions to vaccination against equine influenza.
    Dalgleish R; Love S
    Vet Rec; 1993 Jun; 132(26):658-9. PubMed ID: 8362474
    [No Abstract]   [Full Text] [Related]  

  • 19. A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain.
    Nemoto M; Yamayoshi S; Bannai H; Tsujimura K; Kokado H; Kawaoka Y; Yamanaka T
    Arch Virol; 2019 Sep; 164(9):2355-2358. PubMed ID: 31227892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling equine influenza: Traditional to next generation serological assays.
    Kinsley R; Scott SD; Daly JM
    Vet Microbiol; 2016 May; 187():15-20. PubMed ID: 27066704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.